Skip to main content
logo
BioSmart Co.,Ltd. (KOSDAQ:038460)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,650.00
-40.00 (-1.49%)
At close: Sep 11, 2026

BioSmart Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
562,678482,776484,310456,164391,822189,183
Revenue Growth
20.08%-0.32%6.17%16.42%107.11%13.67%
Gross Profit
87,48985,25682,26279,00676,72968,436
Operating Income
28,12722,66319,4609,7589,3027,960
Net Income
13,4889,009127.1717,907721.311,392
Earnings Per Share
532.38356.456.00556.8337.5772.53
EPS Growth
613.36%5840.85%-98.92%1382.02%-48.20%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
41,30939,11120,84231,34320,28215,274
Total Debt
94,04975,91964,39788,71883,58173,614
Net Cash (Debt)
-52,740-36,808-43,555-57,375-63,298-58,340
Net Cash Growth
------
Net Cash Per Share
-2081.71-1456.33-2054.95-2255.88-3297.14-3038.88

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
19,99424,0733,7081,1666,2891,203
Capital Expenditures
-42,183-33,245-6,922-3,113-4,359-5,332
Free Cash Flow
-22,189-9,172-3,213-1,9471,930-4,129
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
15.55%17.66%16.98%17.32%19.58%36.18%
Operating Margin
5.00%4.69%4.02%2.14%2.37%4.21%
Pretax Margin
4.22%3.05%1.46%4.64%0.50%0.71%
Profit Margin
2.40%1.87%0.03%3.93%0.18%0.74%
FCF Margin
-3.94%-1.90%-0.66%-0.43%0.49%-2.18%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
4.9810.94612.133.9088.6378.72
P/FCF Ratio
----33.13-
PS Ratio
0.120.200.160.150.160.58